30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

More 2010 Results: Alphatec Spine

$171.6MM, +43% (U.S. $119.8MM, +15%; Asia $19.9MM, +67%; Europe $24.2MM, +491%; Rest of World $7.4MM, +100%)

4Q10 revenue: $46MM, +38% (U.S. $32.1MM, +14%; Asia $5.7MM, +75%; Europe $5.6MM, +238%; Rest of World $2.4MM, +100%)
* Full year minimally invasive surgical (MIS) revenues +>480%
* >30% of revenue from ex-U.S.
* Believes U.S. spine market has stabilized; European market will continue to be pressured by potential healthcare budget reductions; Asia and Latin America will see robust growth
* Notes mid-single-digit price impact for entire year
* With Scient’x acquisition, claims #3 position in global pure play spinal implants
* Good adoption of OsseoFix in Germany
* In Europe, OsseoFix used in ~1,900 patients, OsseoScrew in 200 patients
* OsseoScrew 510(k) update: originally submitted 2Q09, but delayed due to issues with instrumentation/retrievability of implant—now worked through, will resubmit in 1H11
* OsseoFix 510(k) update: 1:1, randomized study vs. kyphoplasty; 20 patients in original study will count toward enrollment; enrolled 270 at 30 sites with 1-year follow-up; will complete enrollment in 2011
* ARC Portal & Guided Lumbar Interbody Fusion system full introduction expected 1H11; >50 full sets planned to be in field by end of year
* 2011 launches include facet screw, unique MIS interbody device for TLIF and PLIF
* In 4Q10, focused on increasing/upgrading U.S. distribution network, now at 270 reps
* Encouraged by improving dialogue with FDA